Diabetes enhances leukocyte accumulation in the coronary microcirculation early in reperfusion following ischemia

J Y Hokama1, L S Ritter, G Davis-Gorman

  • 1Section of Cardiovascular and Thoracic Surgery, University of Arizona Heath Sciences Center, Tucson 85724-5071, USA.

Insights

Diabetic hearts show increased leukocyte deposition in coronary microcirculation after ischemia-reperfusion. This early accumulation of leukocytes may worsen inflammation and impair recovery from heart attacks in diabetics.

Area of Science:

  • Cardiovascular Science
  • Diabetology
  • Immunology

Background:

  • Diabetic hearts are highly susceptible to ischemia-reperfusion injury.
  • Leukocyte sequestration in microcirculation is crucial for injury development.
  • Early leukocyte deposition in diabetic coronary microcirculation requires investigation.

Purpose of the Study:

  • To determine if early leukocyte deposition is elevated in the diabetic coronary microcirculation post-myocardial ischemia.
  • To observe leukocyte behavior directly during reperfusion in diabetic and non-diabetic hearts.

Main Methods:

  • Utilized streptozotocin (STZ)-induced diabetic and non-diabetic rat models.
  • Subjected hearts to 30 minutes of no-flow ischemia followed by reperfusion.
  • Employed intravital fluorescence microscopy to visualize labeled leukocyte deposition.
  • Used flow cytometry to measure CD11b expression on polymorphonuclear (PMN) leukocytes.

Main Results:

  • Leukocyte trapping in capillaries and adhesion to venules were significantly increased in diabetic hearts.
  • PMN CD11b adhesion molecule expression was significantly higher in diabetic rats.
  • Direct observation revealed enhanced leukocyte accumulation in diabetic coronary microcirculation.

Conclusions:

  • Leukocytes accumulate rapidly in greater numbers in the diabetic coronary microcirculation early in reperfusion.
  • Enhanced leukocyte retention contributes to inflammation-mediated reperfusion injury in diabetic hearts.
  • This may partially explain the compromised recovery of diabetic hearts following ischemic events.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...